MindMed is a neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics. The company works on addressing the opioid crisis and other forms of addiction by developing versions of psychedelic substances such as LSD, psilocybin and ibogaine without hallucinogenic effects while maintaining their medicinal properties.